Multimodality Molecular Imaging (FDG-PET/CT, US Elastography, and DWI-MRI) as Complimentary Adjunct for Enhancing Diagnostic Confidence in Reported Intermediate Risk Category Thyroid Nodules on Bethesda Thyroid Cytopathology Reporting System
- PMID: 27134564
- PMCID: PMC4809154
- DOI: 10.4103/1450-1147.176883
Multimodality Molecular Imaging (FDG-PET/CT, US Elastography, and DWI-MRI) as Complimentary Adjunct for Enhancing Diagnostic Confidence in Reported Intermediate Risk Category Thyroid Nodules on Bethesda Thyroid Cytopathology Reporting System
Abstract
The potential complimentary role of various molecular imaging modalities [fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT), ultrasound (US)-elastography, and diffusion weighted imaging-magnetic resonance imaging (DWI-MRI)] in characterizing thyroid nodules, which have been designated as "intermediate risk category" on the Bethesda thyroid cytopathology reporting system (BTCRS), is illustrated in this communication. The clinical cases described (category III thyroid nodules on BTCRS) show the imaging features and the final diagnostic impressions rendered by the interpreting physicians with the modalities that have been independently compared in a tabular format at the end; of particular note is the high negative predictive value of these (specifically FDG-PET/CT), which could aid in enhancing the diagnostic confidence in the reported "intermediate risk category" thyroid nodules, a "gray zone" from the patient management viewpoint.
Keywords: Diffusion weighted imaging-magnetic resonance imaging (DWI-MRI); fine-needle aspiration cytology (FNAC); fluorodeoxyglucose-positron emission tomography/computed tomography (18F-FDG-PET/CT); ultrasound (US)-elastography.
Conflict of interest statement
Figures
References
-
- Cibas ES, Ali SZ. NCI Thyroid FNA State of the Science Conference. The bethesda system for reporting thyroid cytopathology. Am J Clin Pathol. 2009;132:658–65. - PubMed
-
- Hirsch D, Robenshtok E, Bachar G, Braslavsky D, Benbassat C. The implementation of the bethesda system for reporting thyroid cytopathology improves malignancy detection despite lower rate of thyroidectomy in indeterminate nodules. World J Surg. 2015 Epub ahead of print. - PubMed
-
- Basu S. Employing Bayesian approach to the intermediate risk categories of the Bethesda thyroid cytopathology reporting system: Can FDG PET/CT find a strong enough evidence-base to be practised clinically as an adjunct? Eur J Nucl Med Mol Imaging. 2014;41:2354–5. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
